Bethany Pitcher

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart et al. · JAMA Oncology · 2017 · 405 citations · Full text

Medicine, Oncology, Pharmacology +13

BRAF Inhibition in <i>BRAF</i> ^V600 -Mutant Gliomas: Results From the VE-BASKET Study

Thomas Kaley, Mehdi Touat, Vivek Subbiah et al. · Journal of Clinical Oncology · 2018 · 331 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)

Catherine Labbé, Michael Cabanero, Grzegorz Korpanty et al. · Lung Cancer · 2017 · 246 citations

Medicine, Molecular Genetics, Oncology +15

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Matthew D. Hellmann, T. W. Kim, Chul‐min Lee et al. · Annals of Oncology · 2019 · 190 citations · Full text

Medicine, Oncology, Pharmacology +11

Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> V600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean‐Yves Blay et al. · Cancer Discovery · 2020 · 125 citations · Full text

Medicine, Oncology, Pharmacology +12